Delivery Order SPE2DR25D3012-SPE2DR26F4F4C
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Ibuprofen 800 mg tablets in quantities of 100, with a ceiling value of $2,324.32. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 20, 2026. This delivery...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 15, 2026, for the supply of Ibuprofen 400 mg tablets in quantities of 500 units. This firm fixed-price delivery order carries a ceiling value of $1,124.96 and is scheduled for ultimate completion by January 16, 2026. The contract was awarded on a competitive, non-set-aside basis and will be performed at the contractor's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ibuprofen 800 mg tablets in quantities of 500 units, with a ceiling value of $1,160.93. This firm fixed-price delivery order is set to be completed by December 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, competitively awarded transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,984.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ibuprofen 800 mg, with a completion date of December 5, 2025. This non-set-aside contract was competitively awarded and represents a direct fulfillment order under AmerisourceBergen's existing federal pharmaceutical supply agreements. The contractor, headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp for the supply of Ibuprofen 800 mg tablets (100-count units) with a ceiling value of $1,035.60. This firm fixed-price contract, awarded on January 22, 2026, is scheduled for ultimate completion by January 23, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award does not include a set-aside designation, indicating the contract was competitively...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,151.85 to AmerisourceBergen Drug Corp for the supply of Ibuprofen 800 mg tablets (500-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on January 2, 2026, with an ultimate completion date of January 5, 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,024.35 to AmerisourceBergen Drug Corp for the supply of Ibuprofen 800 mg tablets in quantities of 500 units. This non-competitive, firm fixed-price delivery order was awarded on December 17, 2025, with an ultimate completion date of December 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 2, 2026, for the supply of Ibuprofen 600 mg tablets in quantities of 30 tablets, with a ceiling value of $1,168.48. This is a firm fixed-price delivery order with an ultimate completion date of January 5, 2026, and represents a non-competitive set-aside award. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,274,156 units of Ibuprofen 800 mg tablets. The contract has an ultimate completion date of February 16, 2022 and a ceiling value of $3,175.07. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations indicated. This delivery order is part of a larger...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $706 to Amerisourcebergen Drug Corporation for ibuprofen tablets. As the prime contractor, Amerisourcebergen will supply 30 tablets of 800mg ibuprofen to fulfill requirements under the contract. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania and must be completed by August 23, 2023. The ordering agency, DLA, manages the procurement of medical supplies and...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4F4CDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Ibuprofen 800 mg tablets in quantities of 100 units. This non-set-aside, competitively awarded contract is valued at $2,005.94 with firm fixed pricing and a completion date of January 23, 2026. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., serves as a major pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and other military healthcare systems. The parent company, Cencora, Inc., holds the primary indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2031. Both entities have demonstrated capability in fulfilling federal requirements through open competition, supplying diverse pharmaceutical products ranging from specialty medications to generic drugs across multiple therapeutic domains essential to military treatment facilities and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/21/26 |